SUBSCRIBE
SUBSCRIBE

Denali Therapeutics Inc.

NEWS
Gemini Therapeutics Banks $42.5M to Bring Precisio
Deals
The 2017 Biotech IPO Winners and Losers
Although it was an average year for mergers and acquisitions in the biopharma industry, it was a stronger year for IPOs.
December 21, 2017
 · 
4 min read
 · 
Mark Terry
Investor
Deals
Denali Raises a Mountain of Cash
A look at what three ex-Genentech employees have accomplished at Denali so far.
December 12, 2017
 · 
1 min read
Investor
Deals
Ex-Genentech Employees’ Denali Breaks 2017 IPO Records, Raises $250M
With the raise, the company’s market valuation is currently $1.7B.
December 8, 2017
 · 
2 min read
 · 
Mark Terry
Roche Could Take a $500M Hit Over Patent Losses
Deals
Run by Former Genentech Employees, Bay Area’s Denali Seeks $100M IPO
Denali plans to make a $100M IPO under the symbol DNLI.
November 14, 2017
 · 
2 min read
 · 
Mark Terry
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
What You Need to Know About Denali Therapeutics
Business
What You Need to Know About Denali
January 3, 2017
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Led by Former Genentech Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
August 25, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Nine Bay Area Biotechs Vie to be the “Next Genentech”
May 24, 2016
 · 
4 min read
Business
Inside the $50 Billion Biotech Sugar Daddy that Invested in Startups Like Denali, Juno
March 3, 2016
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2017
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
June 18, 2026
 · 
7 min read
Press Releases
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 22, 2026
 · 
15 min read
Press Releases
Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
May 8, 2026
 · 
14 min read
Press Releases
Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics’ AVLAYAH™ (tividenofusp alfa-eknm)
April 20, 2026
 · 
2 min read
Press Releases
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
April 5, 2026
 · 
7 min read
Press Releases
Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)
March 25, 2026
 · 
17 min read
Press Releases
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
February 26, 2026
 · 
13 min read
Press Releases
Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™
February 5, 2026
 · 
15 min read
Press Releases
Denali Therapeutics To Host Webcast Highlighting Presentations on Enzyme TransportVehicle™ Programs at the 2026 WORLDSymposium™
February 2, 2026
 · 
1 min read
Press Releases
Denali Therapeutics Announces Data Presentations on Enzyme TransportVehicle™ Programs for Hunter Syndrome, Sanfilippo Syndrome Type A and Pompe Disease at Upcoming 2026 WORLDSymposium™
January 30, 2026
 · 
8 min read
Load More